Loading…
Therapeutic Use of Cloning: Osmangazi Turk Identical Embryonic Stem Cells and Embryonic Stem Cell Transfer to Diabetic Mice
There are important problems in the therapeutic use of cloning which increase with the more advanced differentiation of somatic cells. Problems include DNA reprogramming, tissue rejection, and chromatin remodeling. This study presents the first use in somatic cell nuclear transfer (SCNT) of tooth pu...
Saved in:
Published in: | Journal of Health Science 2009, Vol.55(4), pp.503-515 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c590t-884706bd1b055de4c7ff2827d20a761350500c88e0e68bdf7692256ff2fb83f63 |
---|---|
cites | cdi_FETCH-LOGICAL-c590t-884706bd1b055de4c7ff2827d20a761350500c88e0e68bdf7692256ff2fb83f63 |
container_end_page | 515 |
container_issue | 4 |
container_start_page | 503 |
container_title | Journal of Health Science |
container_volume | 55 |
creator | Gurer, Firdevs Ozden, Hilmi Muslumanoglu, Hamza Baycu, Cengiz Cilingir, Oguz Hassa, Hikmet |
description | There are important problems in the therapeutic use of cloning which increase with the more advanced differentiation of somatic cells. Problems include DNA reprogramming, tissue rejection, and chromatin remodeling. This study presents the first use in somatic cell nuclear transfer (SCNT) of tooth pulp cells containing progenitor cells that resemble the nonaging embryonic connective tissue in adults. Using tooth pulp cells in SCNT increased the first cleavage rates compared with adult somatic cells, leading to a higher rate of DNA reprogramming and increased production of an identical embryonic stem cells (ESCs) line. ESCs derived from tooth pulp cells using this method were observed to transfer into pancreatic β cells using transmission electron microscopy. These cells were named Osmangazi Turk Identical ESCs since this was the first use in SCNT of tooth pulp cells to demonstrate a decrease in glucose levels following administration of these cells. Furthermore, nonidentical ESC perform tissue repair by decreasing glucose levels; however, the renewed tissue was observed to undergo important alterations which affect its future. The prognosis of the therapy of mice with diabetes mellitus using Osmangazi Turk Identical ESC was good, with an 80% therapeutic efficiency. These outcomes are promising for regenerative medicine in the therapy of diabetes mellitus, and clarification of the importance of selecting appropriate adult somatic cells in deriving identical ESC lines is also a significant step. |
doi_str_mv | 10.1248/jhs.55.503 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_21104583</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>21104583</sourcerecordid><originalsourceid>FETCH-LOGICAL-c590t-884706bd1b055de4c7ff2827d20a761350500c88e0e68bdf7692256ff2fb83f63</originalsourceid><addsrcrecordid>eNptkMFu1DAQhiMEEqVw4Ql84oCUZezYscMFoW1LKxX1wPZsOc54N0viLHZyKLw8s92WEwfPjDTf_DP-i-I9hxUX0nza7_JKqZWC6kVxxiupSyVAv3ysZdloEK-LNznvAUQDhp8VfzY7TO6Ay9x7dp-RTYGthyn2cfuZ3eXRxa373bPNkn6ymw4jYW5gl2ObHgjy7MeMI1vjMGTmYve_BtskF3PAxOaJXfSuxeOq773Ht8Wr4IaM757yeXF_dblZX5e3d99u1l9vS68amEtjpIa67XgLSnUovQ5BGKE7AU7XvFKgALwxCFibtgu6boRQNUGhNVWoq_Piw0n3kKZfC-bZjn32dJqLOC3ZCs5BKlMR-PEE-jTlnDDYQ-pHlx4sB3v015K_VilL_hJ8dYJH7I6mTHHoI9r9tKRIv7E-6x26YbYCoLFAt4OkRI-mKXDFhWikJqEvJ6F9nt0W_-10iYwa8HmnfAo0_NzxO5csxuov_Q2bGQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>21104583</pqid></control><display><type>article</type><title>Therapeutic Use of Cloning: Osmangazi Turk Identical Embryonic Stem Cells and Embryonic Stem Cell Transfer to Diabetic Mice</title><source>Freely Accessible Science Journals - check A-Z of ejournals</source><creator>Gurer, Firdevs ; Ozden, Hilmi ; Muslumanoglu, Hamza ; Baycu, Cengiz ; Cilingir, Oguz ; Hassa, Hikmet</creator><creatorcontrib>Gurer, Firdevs ; Ozden, Hilmi ; Muslumanoglu, Hamza ; Baycu, Cengiz ; Cilingir, Oguz ; Hassa, Hikmet ; Faculty of Medicine ; University of Eskisehir Osmangazi ; bDepartment of Anatomy ; dDepartment of Obstetrics and Gynecology ; cDepartment of Genetics ; aDepartment of Histology and Embryology</creatorcontrib><description>There are important problems in the therapeutic use of cloning which increase with the more advanced differentiation of somatic cells. Problems include DNA reprogramming, tissue rejection, and chromatin remodeling. This study presents the first use in somatic cell nuclear transfer (SCNT) of tooth pulp cells containing progenitor cells that resemble the nonaging embryonic connective tissue in adults. Using tooth pulp cells in SCNT increased the first cleavage rates compared with adult somatic cells, leading to a higher rate of DNA reprogramming and increased production of an identical embryonic stem cells (ESCs) line. ESCs derived from tooth pulp cells using this method were observed to transfer into pancreatic β cells using transmission electron microscopy. These cells were named Osmangazi Turk Identical ESCs since this was the first use in SCNT of tooth pulp cells to demonstrate a decrease in glucose levels following administration of these cells. Furthermore, nonidentical ESC perform tissue repair by decreasing glucose levels; however, the renewed tissue was observed to undergo important alterations which affect its future. The prognosis of the therapy of mice with diabetes mellitus using Osmangazi Turk Identical ESC was good, with an 80% therapeutic efficiency. These outcomes are promising for regenerative medicine in the therapy of diabetes mellitus, and clarification of the importance of selecting appropriate adult somatic cells in deriving identical ESC lines is also a significant step.</description><identifier>ISSN: 1344-9702</identifier><identifier>EISSN: 1347-5207</identifier><identifier>DOI: 10.1248/jhs.55.503</identifier><language>eng</language><publisher>The Pharmaceutical Society of Japan</publisher><subject>glucose level ; identical embryonic stem cells ; regenerative medicine ; streptozatocin-diabetes ; therapeutic use of mouse cloning ; β cells</subject><ispartof>Journal of Health Science, 2009, Vol.55(4), pp.503-515</ispartof><rights>2009 by The Pharmaceutical Society of Japan</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c590t-884706bd1b055de4c7ff2827d20a761350500c88e0e68bdf7692256ff2fb83f63</citedby><cites>FETCH-LOGICAL-c590t-884706bd1b055de4c7ff2827d20a761350500c88e0e68bdf7692256ff2fb83f63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Gurer, Firdevs</creatorcontrib><creatorcontrib>Ozden, Hilmi</creatorcontrib><creatorcontrib>Muslumanoglu, Hamza</creatorcontrib><creatorcontrib>Baycu, Cengiz</creatorcontrib><creatorcontrib>Cilingir, Oguz</creatorcontrib><creatorcontrib>Hassa, Hikmet</creatorcontrib><creatorcontrib>Faculty of Medicine</creatorcontrib><creatorcontrib>University of Eskisehir Osmangazi</creatorcontrib><creatorcontrib>bDepartment of Anatomy</creatorcontrib><creatorcontrib>dDepartment of Obstetrics and Gynecology</creatorcontrib><creatorcontrib>cDepartment of Genetics</creatorcontrib><creatorcontrib>aDepartment of Histology and Embryology</creatorcontrib><title>Therapeutic Use of Cloning: Osmangazi Turk Identical Embryonic Stem Cells and Embryonic Stem Cell Transfer to Diabetic Mice</title><title>Journal of Health Science</title><description>There are important problems in the therapeutic use of cloning which increase with the more advanced differentiation of somatic cells. Problems include DNA reprogramming, tissue rejection, and chromatin remodeling. This study presents the first use in somatic cell nuclear transfer (SCNT) of tooth pulp cells containing progenitor cells that resemble the nonaging embryonic connective tissue in adults. Using tooth pulp cells in SCNT increased the first cleavage rates compared with adult somatic cells, leading to a higher rate of DNA reprogramming and increased production of an identical embryonic stem cells (ESCs) line. ESCs derived from tooth pulp cells using this method were observed to transfer into pancreatic β cells using transmission electron microscopy. These cells were named Osmangazi Turk Identical ESCs since this was the first use in SCNT of tooth pulp cells to demonstrate a decrease in glucose levels following administration of these cells. Furthermore, nonidentical ESC perform tissue repair by decreasing glucose levels; however, the renewed tissue was observed to undergo important alterations which affect its future. The prognosis of the therapy of mice with diabetes mellitus using Osmangazi Turk Identical ESC was good, with an 80% therapeutic efficiency. These outcomes are promising for regenerative medicine in the therapy of diabetes mellitus, and clarification of the importance of selecting appropriate adult somatic cells in deriving identical ESC lines is also a significant step.</description><subject>glucose level</subject><subject>identical embryonic stem cells</subject><subject>regenerative medicine</subject><subject>streptozatocin-diabetes</subject><subject>therapeutic use of mouse cloning</subject><subject>β cells</subject><issn>1344-9702</issn><issn>1347-5207</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNptkMFu1DAQhiMEEqVw4Ql84oCUZezYscMFoW1LKxX1wPZsOc54N0viLHZyKLw8s92WEwfPjDTf_DP-i-I9hxUX0nza7_JKqZWC6kVxxiupSyVAv3ysZdloEK-LNznvAUQDhp8VfzY7TO6Ay9x7dp-RTYGthyn2cfuZ3eXRxa373bPNkn6ymw4jYW5gl2ObHgjy7MeMI1vjMGTmYve_BtskF3PAxOaJXfSuxeOq773Ht8Wr4IaM757yeXF_dblZX5e3d99u1l9vS68amEtjpIa67XgLSnUovQ5BGKE7AU7XvFKgALwxCFibtgu6boRQNUGhNVWoq_Piw0n3kKZfC-bZjn32dJqLOC3ZCs5BKlMR-PEE-jTlnDDYQ-pHlx4sB3v015K_VilL_hJ8dYJH7I6mTHHoI9r9tKRIv7E-6x26YbYCoLFAt4OkRI-mKXDFhWikJqEvJ6F9nt0W_-10iYwa8HmnfAo0_NzxO5csxuov_Q2bGQ</recordid><startdate>20090101</startdate><enddate>20090101</enddate><creator>Gurer, Firdevs</creator><creator>Ozden, Hilmi</creator><creator>Muslumanoglu, Hamza</creator><creator>Baycu, Cengiz</creator><creator>Cilingir, Oguz</creator><creator>Hassa, Hikmet</creator><general>The Pharmaceutical Society of Japan</general><general>Pharmaceutical Society of Japan</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>20090101</creationdate><title>Therapeutic Use of Cloning: Osmangazi Turk Identical Embryonic Stem Cells and Embryonic Stem Cell Transfer to Diabetic Mice</title><author>Gurer, Firdevs ; Ozden, Hilmi ; Muslumanoglu, Hamza ; Baycu, Cengiz ; Cilingir, Oguz ; Hassa, Hikmet</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c590t-884706bd1b055de4c7ff2827d20a761350500c88e0e68bdf7692256ff2fb83f63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>glucose level</topic><topic>identical embryonic stem cells</topic><topic>regenerative medicine</topic><topic>streptozatocin-diabetes</topic><topic>therapeutic use of mouse cloning</topic><topic>β cells</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gurer, Firdevs</creatorcontrib><creatorcontrib>Ozden, Hilmi</creatorcontrib><creatorcontrib>Muslumanoglu, Hamza</creatorcontrib><creatorcontrib>Baycu, Cengiz</creatorcontrib><creatorcontrib>Cilingir, Oguz</creatorcontrib><creatorcontrib>Hassa, Hikmet</creatorcontrib><creatorcontrib>Faculty of Medicine</creatorcontrib><creatorcontrib>University of Eskisehir Osmangazi</creatorcontrib><creatorcontrib>bDepartment of Anatomy</creatorcontrib><creatorcontrib>dDepartment of Obstetrics and Gynecology</creatorcontrib><creatorcontrib>cDepartment of Genetics</creatorcontrib><creatorcontrib>aDepartment of Histology and Embryology</creatorcontrib><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Journal of Health Science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gurer, Firdevs</au><au>Ozden, Hilmi</au><au>Muslumanoglu, Hamza</au><au>Baycu, Cengiz</au><au>Cilingir, Oguz</au><au>Hassa, Hikmet</au><aucorp>Faculty of Medicine</aucorp><aucorp>University of Eskisehir Osmangazi</aucorp><aucorp>bDepartment of Anatomy</aucorp><aucorp>dDepartment of Obstetrics and Gynecology</aucorp><aucorp>cDepartment of Genetics</aucorp><aucorp>aDepartment of Histology and Embryology</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Therapeutic Use of Cloning: Osmangazi Turk Identical Embryonic Stem Cells and Embryonic Stem Cell Transfer to Diabetic Mice</atitle><jtitle>Journal of Health Science</jtitle><date>2009-01-01</date><risdate>2009</risdate><volume>55</volume><issue>4</issue><spage>503</spage><epage>515</epage><pages>503-515</pages><issn>1344-9702</issn><eissn>1347-5207</eissn><abstract>There are important problems in the therapeutic use of cloning which increase with the more advanced differentiation of somatic cells. Problems include DNA reprogramming, tissue rejection, and chromatin remodeling. This study presents the first use in somatic cell nuclear transfer (SCNT) of tooth pulp cells containing progenitor cells that resemble the nonaging embryonic connective tissue in adults. Using tooth pulp cells in SCNT increased the first cleavage rates compared with adult somatic cells, leading to a higher rate of DNA reprogramming and increased production of an identical embryonic stem cells (ESCs) line. ESCs derived from tooth pulp cells using this method were observed to transfer into pancreatic β cells using transmission electron microscopy. These cells were named Osmangazi Turk Identical ESCs since this was the first use in SCNT of tooth pulp cells to demonstrate a decrease in glucose levels following administration of these cells. Furthermore, nonidentical ESC perform tissue repair by decreasing glucose levels; however, the renewed tissue was observed to undergo important alterations which affect its future. The prognosis of the therapy of mice with diabetes mellitus using Osmangazi Turk Identical ESC was good, with an 80% therapeutic efficiency. These outcomes are promising for regenerative medicine in the therapy of diabetes mellitus, and clarification of the importance of selecting appropriate adult somatic cells in deriving identical ESC lines is also a significant step.</abstract><pub>The Pharmaceutical Society of Japan</pub><doi>10.1248/jhs.55.503</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1344-9702 |
ispartof | Journal of Health Science, 2009, Vol.55(4), pp.503-515 |
issn | 1344-9702 1347-5207 |
language | eng |
recordid | cdi_proquest_miscellaneous_21104583 |
source | Freely Accessible Science Journals - check A-Z of ejournals |
subjects | glucose level identical embryonic stem cells regenerative medicine streptozatocin-diabetes therapeutic use of mouse cloning β cells |
title | Therapeutic Use of Cloning: Osmangazi Turk Identical Embryonic Stem Cells and Embryonic Stem Cell Transfer to Diabetic Mice |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T22%3A31%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Therapeutic%20Use%20of%20Cloning:%20Osmangazi%20Turk%20Identical%20Embryonic%20Stem%20Cells%20and%20Embryonic%20Stem%20Cell%20Transfer%20to%20Diabetic%20Mice&rft.jtitle=Journal%20of%20Health%20Science&rft.au=Gurer,%20Firdevs&rft.aucorp=Faculty%20of%20Medicine&rft.date=2009-01-01&rft.volume=55&rft.issue=4&rft.spage=503&rft.epage=515&rft.pages=503-515&rft.issn=1344-9702&rft.eissn=1347-5207&rft_id=info:doi/10.1248/jhs.55.503&rft_dat=%3Cproquest_cross%3E21104583%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c590t-884706bd1b055de4c7ff2827d20a761350500c88e0e68bdf7692256ff2fb83f63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=21104583&rft_id=info:pmid/&rfr_iscdi=true |